Skip to main content
    S

    Stevanato Group SpA (STVN)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $19.20
    -0.11 (-0.57%)

    Market Cap: $5.27B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(15/21)
    Avg Surprise
    +4.37%
    Streak
    7 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.18
    Range$0.17 - $0.19
    12 analysts
    EPS Revisions
    1
    0
    7d
    1
    8
    30d
    EPS Estimate DriftChange to current
    90d ago$0.18-2.1%
    60d ago$0.18+0.7%
    30d ago$0.18+0.2%
    7d ago$0.18-0.4%
    Current$0.18
    Revenue Consensus
    $322M
    Range$317M - $328M
    11 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.25
    Range$0.23 - $0.30
    14 analysts
    Revenue Consensus
    $381M
    Range$372M - $391M
    14 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.25---
    Sep 26EST
    		-$0.18---
    Jun 26
    Reported Aug 4
    		$0.16$0.15+6.67%Beat+23.1%
    Mar 26
    Reported May 7
    		$0.13$0.12+8.33%Beat+18.2%
    Dec 25
    Reported Mar 4
    		$0.21$0.17+23.86%Beat+9.8%
    Sep 25
    Reported Nov 6
    		$0.16$0.15+6.67%Beat+23.1%
    Jun 25
    Reported Aug 5
    		$0.13$0.12+8.33%Beat+30.0%
    Mar 25
    Reported May 8
    		$0.11$0.10+10.00%Beat+22.2%
    Dec 24
    Reported Mar 6
    		$0.19$0.18+5.56%Beat+5.6%
    Sep 24
    Reported Nov 5
    		$0.13$0.14-7.14%Miss-18.8%
    Jun 24
    Reported Aug 6
    		$0.10$0.11-9.09%Miss-33.3%
    Mar 24
    Reported May 9
    		$0.09$0.12-25.00%Miss-25.0%
    Dec 23
    Reported Mar 7
    		$0.18$0.19-5.26%Miss+0.0%
    Sep 23
    Reported Oct 31
    		$0.16$0.16+0.00%Beat+6.7%
    Jun 23
    Reported Jul 28
    		$0.15$0.14+7.14%Beat+25.0%
    Mar 23
    Reported May 4
    		$0.12$0.13-7.69%Miss+0.0%
    Dec 22
    Reported Mar 2
    		$0.18$0.16+12.50%Beat+38.5%
    Sep 22
    Reported Nov 8
    		$0.15$0.13+15.38%Beat+25.0%
    Jun 22
    Reported Aug 4
    		$0.12$0.12+0.00%Beat-14.3%
    Mar 22
    Reported May 10
    		$0.12$0.11+9.09%Beat-70.7%
    Dec 21
    Reported Mar 8
    		$0.13$0.10+30.00%Beat-26.3%
    Sep 21
    Reported Nov 9
    		$0.12$0.11+9.09%Beat+270.4%
    Jun 21
    Reported Aug 19
    		$0.14$0.15-6.67%Miss-
    Mar 21
    Reported Jun 2
    		$0.41$0.00N/ABeat-
    Dec 20
    Reported Mar 31
    		$0.18$0.00N/ABeat-
    Dec 19
    Reported Mar 31
    		$0.03$0.00N/ABeat-

    Dividends

    Dividend Metrics

    Forward Yield0.32%
    Forward Annual Dividend$0.06
    Payout Ratio10.83%
    FrequencyAnnual
    Pay MonthsJul

    Growth

    3Y CAGR+4.71%

    Key Metrics

    Valuation
    P/E Ratio25.07EV/EBITDA16.38x
    Price/FCF-180.23xFCF Yield-0.55%
    Profitability
    Profit Margin11.00%Operating Margin17.20%
    ROE9.13%ROIC7.25%
    Financial Health
    Debt/Equity0.28xInterest Coverage21.15x
    Current Ratio1.61xQuick Ratio1.08x
    Trading Statistics
    Beta0.78Avg Volume318.82K
    52-Week High$27.8952-Week Low$12.84

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$19.52
    SMA 20$20.39
    SMA 50$20.96
    SMA 200$18.15
    EMA 10$19.60
    EMA 20$20.09
    EMA 50$20.37
    EMA 200$19.65

    MACD

    Line: -0.54Signal: -0.40Hist: -0.14

    ADX

    ADX: 22.0+DI: 13.4-DI: 23.0

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down92.0
    PSAR$20.58

    Bollinger Bands

    Upper Band$22.39
    Lower Band$18.39
    %B Position1962%(Upper)
    Band Width0.20

    RSI (14-Day)

    Neutral
    34.0

    Momentum Oscillators

    Stoch %K15.6
    Stoch %D14.0
    Williams %R-86.2
    ROC (10d)-3.9%
    Momentum-0.78
    CCI (20d)-84.9
    MFI (14d)42.0

    Volatility Measures

    ATR (14d)$0.75(3.9%)
    StdDev (20d)1.00
    Hist Vol25.0%(Moderate)

    Volume Flow

    VWAP$19.30
    OBV-4.2M
    AD Line-27.0M
    CMF (20d)-0.162

    Volume Metrics

    Avg Vol (20d)295.2K
    Vol Ratio1.5x
    VWMA (20d)$20.30

    Pivot Points

    R3$20.09
    R2$19.82
    R1$19.56
    Pivot Point$19.29
    S1$19.03
    S2$18.76
    S3$18.50

    Advanced Oscillators

    TSI-24.78
    Ultimate Osc40.1
    KST-81.59

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$302.00M$273.57M$343.25M$303.17M$280.04M$256.60M$330.60M$277.87M$259.58M$235.99M$320.64M$271.42M
    Cost of Revenue$215.20M$198.40M$237.35M$214.67M$201.45M$186.71M$232.44M$203.42M$192.06M$173.80M$218.80M$188.52M
    Gross Profit$86.80M$75.18M$105.90M$88.50M$78.59M$69.89M$98.15M$74.44M$67.52M$62.20M$101.83M$82.89M
    Operating Expenses$47.70M$36.44M$39.92M$35.78M$37.22M$35.26M$31.30M$33.42M$39.55M$36.91M$37.79M$31.73M
    R&D$6.20M$5.84M$5.75M$7.65M$6.04M$5.93M$5.57M$6.61M$8.74M$10.75M$10.07M$8.69M
    SG&A$23.60M$23.49M$25.66M$23.78M$24.76M$24.52M$25.36M$22.32M$22.57M$21.50M$23.57M$20.24M
    Operating Income$39.10M$38.74M$65.98M$52.72M$41.37M$34.63M$66.86M$41.03M$27.97M$25.29M$64.05M$51.16M
    Interest Income$338,000$281,000$216,000$390,000$39,000$360,000$81,000$532,000$974,000$135,000$166,000$4.80M
    Interest Expense$2.00M$1.17M$4.56M$1.77M$1.70M$1.43M$2.96M$1.58M$837,000$1.49M$1.53M$1.14M
    Income Before Tax$38.10M$39.24M$65.18M$49.13M$39.11M$35.11M$64.65M$40.79M$29.17M$25.68M$58.79M$50.40M
    Income Tax Expense$15.10M$11.21M$18.03M$13.06M$9.41M$8.60M$16.34M$10.77M$8.55M$6.86M$13.56M$12.51M
    Net Income$23.00M$28.03M$47.15M$36.06M$29.70M$26.52M$48.31M$30.03M$20.63M$18.81M$45.23M$37.89M
    EBITDA$64.29M$65.06M$94.33M$72.68M$62.38M$57.16M$87.31M$103.32M$50.95M$47.89M$80.38M$72.08M
    EBIT$40.10M$40.41M$69.74M$50.90M$40.81M$36.54M$67.61M$42.37M$30.10M$26.22M$60.32M$51.54M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about STVN

    News

    Fenimore Asset Management Inc Buys 582,070 Shares of Stevanato Group S.p.A. $STVN

    Fenimore Asset Management Inc has acquired 582,070 shares of Stevanato Group S.p.A. (NYSE:STVN) for approximately $12.2 million...

    MarketBeat•10/8/26•Neutral

    Deutsche Bank Aktiengesellschaft Initiates Coverage on Stevanato Group (NYSE:STVN)

    Deutsche Bank Aktiengesellschaft has initiated coverage on Stevanato Group (NYSE:STVN) with a "hold" rating. This decision aligns with the company's "Moderate Buy" consensus rating from other analysts. Stevanato Group...

    MarketBeat•10/7/26•Neutral

    Behavioral Patterns of STVN and Institutional Flows

    This article analyzes Stevanato Group S.p.a. (NASDAQ: STVN), identifying a weak sentiment across all time horizons and suggesting a short bias. It details an exceptional 66.2:1 risk-reward short setup targeting 18.1%...

    Stock Traders Daily•10/3/26•Bearish

    Stevanato Group S.p.A. (STVN) Stock Price, News, Quote & History

    Stevanato Group S.p.A. (STVN) stock closed at $20.20, up 1.10% on October 2, 2026. The company, which specializes in medical instruments and supplies for the biopharma and healthcare industries...

    Yahoo! Finance Canada•10/3/26•Somewhat-Bullish

    Stevanato Group (NYSE:STVN) Stock Falls 6.2% After Insider Selling

    Stevanato Group (NYSE:STVN) shares dropped 6.2% following an insider sale by Mauro Stocchi, who offloaded 13,649 shares for approximately €293,454. Despite this...

    MarketBeat•10/1/26•Somewhat-Bearish

    STVN Valuation and Fair Value

    P/E
    25.1x
    Forward P/E
    29.1x
    EV/EBITDA
    16.4x
    P/FCF
    -180.2x
    PEG
    1.6x
    P/B
    3.0x
    See GNG's fair value

    STVN Profitability: Margins, ROIC and FCF

    Gross margin
    29.2%
    Operating margin
    17.2%
    Net margin
    11.0%
    ROIC
    7.3%
    ROE
    9.1%
    FCF margin
    -1.8%
    FCF yield
    -0.6%

    STVN Competitors

    CompanyTicker
    RadNet IncRDNT
    Teleflex IncorporatedTFX
    Doximity IncDOCS
    Merit Medical Systems IncMMSI
    CG Oncology, Inc. Common stockCGON
    Mirum Pharmaceuticals IncMIRM
    Haemonetics CorporationHAE
    Waystar Holding Corp. Common StockWAY

    Sector: Healthcare

    STVN Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    2
    Buy
    7
    Hold
    4
    Sell
    0
    Strong Sell
    0

    STVN Bull Case vs Bear Case

    Bull case

    • STVN beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 69.2% of STVN's analyst ratings are Buy or Strong Buy.

    STVN Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    7.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.18
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 8 down

    STVN Dividend

    Forward yield
    0.3%
    Payout ratio
    10.8%
    3Y DPS growth
    4.7%
    Pay months
    Jul

    Frequently Asked Questions About STVN

    What is STVN's current dividend yield?

    Stevanato Group SpA (STVN) has a forward dividend yield of 0.32%.

    Does STVN pay dividends?

    Yes, Stevanato Group SpA pays dividends with a forward dividend yield of 0.32%.

    What is STVN's P/E ratio?

    Stevanato Group SpA has a price-to-earnings (P/E) ratio of 25.07.

    What is STVN's market cap?

    Stevanato Group SpA (STVN) has a market capitalization of $5.27B with a current stock price of $19.20.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In